CRISPR Therapeutics

Cambridge, Massachusetts, USA
508 Total Employees
Year Founded: 2013

Similar Companies Hiring

Software • Pharmaceutical • Healthtech • Biotech
Wakefield, MA
650 Employees
Healthtech • Biotech • App development
Boston, MA
150 Employees
Software • Pharmaceutical • Machine Learning • Biotech • Big Data • Artificial Intelligence • Analytics
Lexington, MA
63000 Employees

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.


CRISPR Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
Cambridge, Massachusetts, USA